Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 60 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesChong, C.; Chan, W.; Nguyen, T.; Liu, S.; Procter, N.; Ngo, D.; Sverdlov, A.; Chirkov, Y.; Horowitz, J.
2008Identifying clopidogrel resistance during chronic therapy: The case for a biochemical approachHorowitz, J.; Chirkov, Y.
2010Perhexiline and hypertrophic cardiomyopathy: A new horizon for metabolic modulationHorowitz, J.; Chirkov, Y.
2012Can we make sense of takotsubo cardiomyopathy? An update on pathogenesis, diagnosis and natural historyNeil, C.; Nguyen, T.; Sverdlov, A.; Chirkov, Y.; Chong, C.; Stansborough, J.; Beltrame, J.; Kucia, A.; Zeitz, C.; Frenneaux, M.; Horowitz, J.
2014Hypoxic potentiation of nitrite effects in human vessels and plateletsDautov, R.; Stafford, I.; Liu, S.; Cullen, H.; Chirkov, Y.; Horowitz, J.
2014Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeuticsProcter, N.; Chong, C.; Sverdlov, A.; Chan, W.; Chirkov, Y.; Horowitz, J.
1996Multiple agonist induction of aggregation: an approach to examine anti-aggregating effects in vitroWilloughby, S.; Chirkova, L.; Horowitz, J.; Chirkov, Y.
2014B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjectsLiu, S.; Ngo, D.; Stewart, S.; Horowitz, J.; Chirkov, Y.
2012Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patientsWilloughby, S.; Rajendran, S.; Chan, W.; Procter, N.; Leslie, S.; Liberts, E.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.
1996Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectorisChirkov, Y.; Chirkova, L.; Horowitz, J.